These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10404358)

  • 1. Tissue-plasminogen activator fibrinolysis.
    Osher RH
    J Cataract Refract Surg; 1999 Jul; 25(7):880. PubMed ID: 10404358
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolysis of postcataract fibrin membranes in children.
    Leung AT; Lam DS; Rao SK
    J Cataract Refract Surg; 2000 Jan; 26(1):4; author reply 5. PubMed ID: 10646130
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinolysis of postcataract fibrin membranes in children.
    Mehta JS; Adams GG
    J Cataract Refract Surg; 2000 Jan; 26(1):4-5. PubMed ID: 10646131
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children.
    Klais CM; Hattenbach LO; Steinkamp GW; Zubcov AA; Kohnen T
    J Cataract Refract Surg; 1999 Mar; 25(3):357-62. PubMed ID: 10079440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined thrombolysis by pharmacokinetically different plasminogen activators].
    Maksimenko AV
    Bioorg Khim; 1998 May; 24(5):376-80. PubMed ID: 9661792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitis].
    Chiseliţă D; Antohi I; Cionca D; Medvichi R; Cimpoeşu D
    Oftalmologia; 2006; 50(2):68-72. PubMed ID: 16927762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.
    Ozveren F; Eltutar K
    J Cataract Refract Surg; 2004 Aug; 30(8):1727-31. PubMed ID: 15313298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of topically administered tissue plasminogen activator for intraocular fibrinolysis in dogs.
    Gerding PA; Hamor RE; Ramsey DT; Vasaune S; Schaeffer DJ
    Am J Vet Res; 1994 Oct; 55(10):1368-70. PubMed ID: 7998691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current developments in fibrinolytic therapy].
    Rijken DC
    Ned Tijdschr Geneeskd; 1985 Sep; 129(37):1768-72. PubMed ID: 3934567
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracameral injection of tissue plasminogen activator to treat severe postoperative fibrinous reaction in iridocorneal endothelial syndrome.
    Hong BK; Francis BA
    Digit J Ophthalmol; 2013; 19(2):21-3. PubMed ID: 24109245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion.
    Kattah JC; Wang DZ; Reddy C
    Arch Ophthalmol; 2002 Sep; 120(9):1234-6. PubMed ID: 12215107
    [No Abstract]   [Full Text] [Related]  

  • 12. Report of tissue plasminogen activator (tPA) injection in a very low dose for the treatment of posttrabeculectomy fibrin.
    Burnstein Y; Higginbotham EJ
    J Glaucoma; 1998 Oct; 7(5):361. PubMed ID: 9786567
    [No Abstract]   [Full Text] [Related]  

  • 13. Lower dose intraventricular T-PA fibrinolysis: case report.
    Deutsch H; Rodriguez JC; Titton RL
    Surg Neurol; 2004 May; 61(5):460-3; discussion 463. PubMed ID: 15120223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous tissue plasminogen activator in central retinal artery occlusion.
    Falavarjani KG; Modarres M
    Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue plasminogen activator in the management of anterior chamber fibrin formation.
    Erol N
    J Cataract Refract Surg; 2004 Nov; 30(11):2254-5; author reply 2255. PubMed ID: 15519061
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue plasminogen activator after retinal artery occlusion.
    Marmor MF
    Ophthalmology; 1999 Dec; 106(12):2231-2. PubMed ID: 10599645
    [No Abstract]   [Full Text] [Related]  

  • 17. Recanalization of occluded modified Blalock-Taussig shunt using topical recombinant tissue plasminogen activator with balloon angioplasty.
    Suda K; Matsumura M; Matsumoto M
    Cardiol Young; 2004 Jun; 14(3):322-3. PubMed ID: 15680027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of intracameral fibrinous membranes with tissue plasminogen activator.
    Erol N; Ozer A; Topbas S; Yildirim N; Yurdakul S
    Ophthalmic Surg Lasers Imaging; 2003; 34(6):451-6. PubMed ID: 14620747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.